How to Get Paid Every Month

The cash-flow story is the point. On the Q2 call, CFO Scott Reents told analysts AbbVie has “strong cash flows, balance sheet, and business outlook” and “substantial financial flexibility to pursue additional innovative business development.” Skyrizi hit $5.5 billion in the quarter, up 24% operationally, and Rinvoq cleared $2.5 billion, up 23.7%. Management lifted full-year adjusted EPS guidance to $13.87 to $14.07.

Here’s the catch: the reported profitability was depressed by acquisition accounting, which pushes the trailing PE to 75x even though forward PE is 19x. Investors that are seriously relying on the payout should track leverage after the Apogee deal closes. Management committed to a net leverage ratio of two times within two to three years following the deal close. Shares have run 30.1% over the past year.

Chevron: March, June, September, December

Chevron declared its latest $1.78 quarterly payout on July 29, 2026, with a record date of August 19, 2026 and payment on September 10, 2026. That marks a step up from $1.71 in 2025 and $1.63 in 2024. Trailing 12-month payouts total $7.05, with the annualized forward at $7.12. Yield sits at 3.44%.

The Q2 report gave dividend investors what they wanted: adjusted earnings of $12 billion, or $6.06 per share, adjusted free cash flow of $15.4 billion, and debt reduction of more than $8 billion in the quarter. Net debt to cash flow from operations closed at 0.6 times. CEO Mike Wirth told the call, “Consistent with our longstanding financial priorities, we intend to reward our shareholders today tomorrow and long into the future.” The Hess assets are generating strong free cash flow, which has been roughly double the incremental dividends and accretive to shareholders on a per share basis.

Chevron shares are up 35.01% year to date and 32.22% over the past year. Forward PE is 13x.

Putting the Ladder Together

Equal-weighted, these three names blend to a yield around 4%, with concentrated exposures worth noting: tobacco regulation for Altria, biosimilar and pipeline execution for AbbVie, and commodity prices for Chevron. That mix is the reason the ladder works. When crude cracks widen, Chevron benefits. When defensive consumer names catch a bid, Altria carries the load. AbbVie sits in the middle as a healthcare hedge with a growing payout. If a three-stock stagger still feels too rough, there is another route: funds and stocks that cut a check every 30 days on their own, seven of which we lined up in a free report here: The 7 Monthly Dividend Stocks That Pay You Every 30 Days. The next event on the calendar: Chevron pays on September 10, 2026. Keep an eye on the stock and the ex-date if you want to be included in the next round.

What Happens After A $1,000,000 Retirement?

How do you continue to grow a seven-figure portfolio in retirement? The last thing you want is to run out of money, you want your money to generate lasting income while you enjoy your life.

Learn seven strategies high net worth investors use with new report: The Seven Secrets of High Net Worth Investors from Fisher Investments. Get your guide here (sponsor)

Contact editorial@247wallst.com for any questions or corrections.